https://scholars.lib.ntu.edu.tw/handle/123456789/570227
標題: | Oral lichen planus – Differential diagnoses, serum autoantibodies, hematinic deficiencies, and management | 作者: | CHUN-PIN CHIANG JULIA YU-FONG CHANG YI-PING WANG Wu Y.-H. Lu S.-Y. ANDY SUN |
公開日期: | 2018 | 出版社: | Elsevier B.V. | 卷: | 117 | 期: | 9 | 起(迄)頁: | 756-765 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | Oral lichen planus (OLP) is a chronic inflammatory oral mucosal disease that occurs more frequently in middle-aged and elderly female patients. Previous studies indicate that OLP is a T-cell dysfunction-induced localized autoimmune disease. Clinically, six types of OLP, namely reticular, papular, plaque-like, atrophic/erosive, ulcerative, and bullous types, can be identified. OLP more commonly affects buccal mucosa, tongue, and gingiva. It always has a bilateral and symmetric distribution of the oral lesions. Plaque-like and atrophic/erosive OLP may be misdiagnosed as oral leukoplakia and oral erythroleukoplakia, respectively. Our previous study found serum autoantibodies in 195 (60.9%) of the 320 OLP patients. Specific serum anti-nuclear, anti-smooth muscle, anti-mitochondrial, gastric parietal cell, thyroglobulin, and thyroid microsomal autoantibodies are present in 28.1%, 8.4%, 1.6%, 26.3%, 21.3%, and 24.4% of 320 OLP patients, respectively. Furthermore, we also discovered that 21.9%, 13.6%, 7.1%, 0.3%, and 14.8% of 352 OLP patients have hemoglobin, iron, vitamin B12, and folic acid deficiencies, and abnormally high serum homocysteine level, respectively. Therefore, it is very important to examine the serum autoantibody, hematinic and homocysteine levels in OLP patients before starting the treatments for OLP patients. Because OLP is an immunologically-mediated disease, corticosteroids are the drugs of choice for treatment of OLP. ? 2018 |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042147901&doi=10.1016%2fj.jfma.2018.01.021&partnerID=40&md5=91ade80a5a3847060b2fd0874f84e455 https://scholars.lib.ntu.edu.tw/handle/123456789/570227 |
ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2018.01.021 | SDG/關鍵字: | antianemic agent; antinuclear antibody; autoantibody; corticosteroid; homocysteine; levamisole; thyroglobulin; triamcinolone acetonide; autoantibody; allergic reaction; anemia; antibody blood level; blood cell count; chronic graft versus host disease; contact allergy; corticosteroid therapy; cyanocobalamin deficiency; differential diagnosis; disease classification; erosive oral lichen planus; erosive oral lichen planus; erythroleukoplakia; folic acid deficiency; hepatitis C; histopathology; human; immunofluorescence; iron deficiency; leukoplakia; lichen planus; lichen planus pemphigoides; lupus erythematosus; mouth lesion; oral lichen planus; oral mucosal disease; pathogenesis; Review; stomach parietal cell; stomatitis; adverse drug reaction; blood; carcinogenesis; classification; complication; graft versus host reaction; lichen planus; mouth; pathology; Autoantibodies; Carcinogenesis; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Graft vs Host Disease; Hematinics; Humans; Lichen Planus, Oral; Mouth |
顯示於: | 臨床牙醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。